Your browser doesn't support javascript.
loading
Study protocol of a phase II study to evaluate safety and efficacy of neo-adjuvant pembrolizumab and radiotherapy in localized rectal cancer.
Corrò, Claudia; Buchs, Nicolas C; Tihy, Matthieu; Durham-Faivre, André; Bichard, Philippe; Frossard, Jean-Louis; Puppa, Giacomo; McKee, Thomas; Roth, Arnaud; Zilli, Thomas; Trembleau, Christelle; Di Marco, Mariagrazia; Dutoit, Valérie; Dietrich, Pierre-Yves; Ris, Frédéric; Koessler, Thibaud.
Affiliation
  • Corrò C; Translational Research Center in Onco-Hematology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Buchs NC; Swiss Cancer Center Léman, Geneva and Lausanne, Switzerland.
  • Tihy M; Department of Oncology, Geneva University Hospital, Geneva, Switzerland.
  • Durham-Faivre A; Department of Visceral Surgery, Geneva University Hospital, Geneva, Switzerland.
  • Bichard P; Department of Pathology, Geneva University Hospital, Geneva, Switzerland.
  • Frossard JL; Department of Radio-Oncology, Geneva University Hospital, Geneva, Switzerland.
  • Puppa G; Department of Gastroenterology, Geneva University Hospital, Geneva, Switzerland.
  • McKee T; Department of Gastroenterology, Geneva University Hospital, Geneva, Switzerland.
  • Roth A; Department of Pathology, Geneva University Hospital, Geneva, Switzerland.
  • Zilli T; Department of Pathology, Geneva University Hospital, Geneva, Switzerland.
  • Trembleau C; Department of Oncology, Geneva University Hospital, Geneva, Switzerland.
  • Di Marco M; Department of Radio-Oncology, Geneva University Hospital, Geneva, Switzerland.
  • Dutoit V; Department of Oncology, Geneva University Hospital, Geneva, Switzerland.
  • Dietrich PY; Department of Oncology, Geneva University Hospital, Geneva, Switzerland.
  • Ris F; Translational Research Center in Onco-Hematology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Koessler T; Swiss Cancer Center Léman, Geneva and Lausanne, Switzerland.
BMC Cancer ; 22(1): 772, 2022 Jul 15.
Article de En | MEDLINE | ID: mdl-35840912

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du rectum / Traitement néoadjuvant Type d'étude: Clinical_trials Limites: Humans Langue: En Journal: BMC Cancer Sujet du journal: NEOPLASIAS Année: 2022 Type de document: Article Pays d'affiliation: Suisse Pays de publication: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du rectum / Traitement néoadjuvant Type d'étude: Clinical_trials Limites: Humans Langue: En Journal: BMC Cancer Sujet du journal: NEOPLASIAS Année: 2022 Type de document: Article Pays d'affiliation: Suisse Pays de publication: Royaume-Uni